May 02

AHRQ awards $1.

PCMH is a style of treatment that replaces episodic treatment with a long-term physician-patient relationship centered on coordinated, accessible, extensive care. Features of the medical home include usage of care, affected person engagement and team-based treatment. The extensive research will assess the advantages and disadvantages of each pilot on patient experience, cost, quality and outcomes. The three-calendar year grant will analyze promises data from the pilot practices of each plan from 2009, when the pilots were launched, through 2011. Concern Health and Independent Health offer an ideal comparison opportunity since both are community-based health plans , which began pilot tasks in ’09 2009.The analysis found: 682 Ontarians filling prescriptions through Ontario’s Community Drug Programs were newly treated with a DMD for MS between April 2006 and March 2008 Although DMDs differ regarding rate of recurrence of injection, costs and side-effect profiles, there is no indication that adherence to these medicines varies in Ontario Despite their efficacy substantially, adherence to all or any DMDs can be low, with less than half of patients continually adherent after 2 years. ‘This study implies that adherence to treatment with DMDs is normally low, which is regarding given their proven effectiveness in slowing the progression of MS.